For most companies, making a product for which theres guaranteed demand Around The World sounds too good to be true, but a successful covid 19 vaccine promises to be just that. One vaccine shot, or a couple as your first booster, is not going to provide lifetime immunity to the virus, so the manufacturers are set to reap the profits for years to come. Drug maker pfizer reports its earnings later today, the question is which of the drugs firms are going to come out on top, and how lucrative Will Making Vaccines actually turn out to be . Joining me now is Sunaina Sinha haldea, managing partner, cebile capital. Thank you for being on the program. First of all, pfizer, when it comes to its news today. This will obviously not have in todays earnings, profits it is going to make with this vaccine it has come up with this vaccine it has come up with biontech . M0 with this vaccine it has come up with biontech . With this vaccine it has come up with biontech . No it wont. There will up with bi
Imagine. It is wonderful to have you all here with us this evening at the museum and also to all of you at home who are watching via cspan. We have this evening a wonderful presentation by john browne and then followed by a discussion with professor daniel of rice university. Without further ado i will hand it over to john browne. Help me welcome mr. Browne to houston. [applause] ladies and gentlemen, i want to thank the Houston Museum of Natural Science for inviting me. As someone who served on the boards of several museums and galleries i have a deep appreciation for the role that institutions like this play in the local community and indeed in society more generally. As a window on the path and an explainer of the present and as a guide to the future they are indispensable resources which go above and beyond what you can read in books. Houston is fortunate to have this place and it is a great pleasure to be here. As a natural scientist and subsequently an engineer ive always sought
Museum, and also to all of you at home who are watching via cspan. We have this evening a wonderful presentation by lord browne, and then followed by discussion with professor Daniel Minisini of rice university. So without further ado im going to hand it over to lord browne come help me welcome john browne to houston. [applause] ladies and gentlemen, i want to thank the Houston Museum of Natural Science for inviting me, to spend some time this week. For someone who is on the boards of several museums and galleries, i have a deep appreciation for the role that institutions like this play in the local community and, indeed, in society more generally. As a window on the past and explainer of the present and a guide to the future, they are indispensable resources which go above and beyond what you can read in books. Houston is fortunate to have this place, and its a great pleasure to be here. As a natural scientist and subsequently an engineer, ive always sought to maintain a Broad Perspec
Congress also had asked acted in ways that demonstrated a transition was a different kind period. Afterwards airs on booktv every saturday at 10 00 p. M. And sunday at 9 00 p. M. Eastern. You can watch all previous afterwards programs on our web site booktv. Org. Now on booktv Charlotte Jacobs remembers the life and career of jonas salk, creator of the polio vaccine. She is joined in conversation by Janet Napolitano, president of the university of california and former secretary of Homeland Security. Good evening and welcome to todays meeting of the Commonwealth Club of california, this is the place where you are in the know. You can find us online at commonwealthclub. Org, find us on facebook and twitter and on the clubs Youtube Channel as well. I am 8 share of the commonwealth board of governors and i am going to chair todays program. This program is part of the clubs good list ceres underwritten by the bernard foundation. 60 years ago, physician, researcher jonas salk changed Human
The appropriations subcommittee on labor health and Human Services education and related agencies will come to order. Im certainly pleased we could have this opportunity this morning, dr. Collins, to talk to you and the other Institute Directors about the work youre doing and the work youd like to do. Certainly every family faces Health Concerns during their lifetime and there are so many things that can be done by nih that i think cant be done as well anywhere else. A new drug, a new device, new treatment can take anywhere from a decade to longer to develop, can cost billions of dollars on occasion with a pretty high failure rate, even when you think youre on the right path. Certainly its necessary for the federal government to invest in Biomedical Research. It represents the hopes of lots of people and lots of families and particularly now as we see conditions growing as people survive heart problems and stroke problems, we see more people with alzheimers and cancer challenges. We se